Integra LifeSciences Holdings (IART)

Currency in USD
14.10
+0.48(+3.52%)
Real-time Data·
IART Scorecard
Full Analysis
Operates with a significant debt burden
IART is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.6614.24
52 wk Range
11.0627.13
Key Statistics
Prev. Close
13.62
Open
13.81
Day's Range
13.66-14.24
52 wk Range
11.06-27.13
Volume
732.21K
Average Volume (3m)
1.27M
1-Year Change
-36.06%
Book Value / Share
13.37
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IART Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.88
Upside
+12.59%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Integra LifeSciences Holdings Company Profile

Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company addresses the needs of plastic, and reconstructive and general surgeons focused on the treatment of acute wounds, such as burns and chronic wounds, including diabetic foot ulcers; and provides surgical tissue repair products for hernia, tendon, peripheral nerve repair, and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. Further, it is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Integra LifeSciences Holdings Earnings Call Summary for Q2/2025

  • Q2 2025 revenue of $415.6M beat expectations; adjusted EPS of $0.45 slightly surpassed forecasts
  • Stock rose 5.5% pre-market despite 29% YoY decline in adjusted EPS and 450bps drop in gross margin
  • Full-year guidance: revenue $1.655B-$1.68B, EPS $2.19-$2.29; Q3 outlook: revenue $410M-$420M, EPS $0.40-$0.45
  • CEO confident in ongoing transformation, maintaining leadership in neurosurgery and tissue technology markets
  • Challenges include supply chain issues, market competition, and potential impacts from proposed Medicare changes
Last Updated: 31/07/2025, 16:16
Read Full Transcript

Compare IART to Peers and Sector

Metrics to compare
IART
Peers
Sector
Relationship
P/E Ratio
−2.2x−12.8x−0.5x
PEG Ratio
0.000.520.00
Price/Book
1.1x5.8x2.6x
Price / LTM Sales
0.7x3.7x3.3x
Upside (Analyst Target)
−6.6%151.3%40.6%
Fair Value Upside
Unlock−12.3%5.3%Unlock

Analyst Ratings

3 Buy
5 Hold
4 Sell
Ratings:
12 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 15.88
(+12.59% Upside)

Earnings

Latest Release
Jul 31, 2025
EPS / Forecast
0.45 / 0.44
Revenue / Forecast
415.60M / 395.04M
EPS Revisions
Last 90 days

IART Income Statement

People Also Watch

247.40
AVAV
-0.93%
23.755
METC
-11.86%
28.48
CNC
+5.74%
8.95
PAGS
+2.29%
121.05
TFX
-0.09%

FAQ

What Stock Exchange Does Integra Trade On?

Integra is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Integra?

The stock symbol for Integra is "IART."

What Is the Integra Market Cap?

As of today, Integra market cap is 1.09B.

What Is Integra's Earnings Per Share (TTM)?

The Integra EPS (TTM) is -6.54.

When Is the Next Integra Earnings Date?

Integra will release its next earnings report on 28 Oct 2025.

From a Technical Analysis Perspective, Is IART a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Integra Stock Split?

Integra has split 2 times.

How Many Employees Does Integra Have?

Integra has 4396 employees.

What is the current trading status of Integra (IART)?

As of 15 Aug 2025, Integra (IART) is trading at a price of 14.10, with a previous close of 13.62. The stock has fluctuated within a day range of 13.66 to 14.24, while its 52-week range spans from 11.06 to 27.13.

What Is Integra (IART) Price Target According to Analysts?

The average 12-month price target for Integra is USD15.875, with a high estimate of USD30 and a low estimate of USD10. 3 analysts recommend buying the stock, while 4 suggest selling, leading to an overall rating of Neutral. The stock has an +12.59% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.